Get the Stockscreener App
0.4795
7.04%
-0.0363
After Hours:
.48
0.0005
+0.10%
Profusa Inc stock is traded at $0.4795, with a volume of 191.62K.
It is down -7.04% in the last 24 hours and down -44.57% over the past month.
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
See More
Previous Close:
$0.5158
Open:
$0.5055
24h Volume:
191.62K
Relative Volume:
0.04
Market Cap:
$2.11M
Revenue:
$75,000
Net Income/Loss:
$-40.08M
P/E Ratio:
-0.00247
EPS:
-193.9456
Net Cash Flow:
$-16.26M
1W Performance:
-13.91%
1M Performance:
-44.57%
6M Performance:
-96.56%
1Y Performance:
+0.00%
1-Day Range:
$0.4702
$0.5156
1-Week Range:
$0.4357
$0.5495
52-Week Range:
$0.4101
$166.50
Profusa Inc Stock (PFSA) Company Profile
Name
Profusa Inc
Sector
Industry
Phone
212-494-9022
Address
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.4795 | 2.27M | 75,000 | -40.08M | -16.26M | -193.95 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc Stock (PFSA) Latest News
Profusa granted transfer to Nasdaq Capital Market, faces July compliance deadline - MSN
Number of shareholders of PROFUSA, INC. – OTC:NVACW - TradingView
Profusa Granted Conditional Nasdaq Listing Extension and Transfer - TipRanks
Profusa, Inc. Granted Transfer to Nasdaq Capital Market Amid Compliance Efforts - Quiver Quantitative
Conditional Nasdaq listing relief for Profusa (NASDAQ: PFSA) - Stock Titan
Profusa Receives Favorable Nasdaq Listing Determination - Caledonian Record
Profusa keeps Nasdaq listing if it meets July 6 price and equity rules - Stock Titan
PFSA Technical Analysis & Stock Price Forecast - Intellectia AI
Profusa Secures New Convertible Note and Warrant Financing - TipRanks
Profusa (PFSA) insider-linked LLC converts $1.87M note into 5.34M shares - Stock Titan
Profusa (PFSA) CFO-linked LLC converts $1,869,796 note into 5.34M shares - Stock Titan
Profusa initiates strategic review, focuses on European approval By Investing.com - Investing.com Australia
Profusa initiates strategic review, focuses on European approval - Investing.com
Profusa Inc Profusa initiates board-led process to evaluate strategic alternatives and maximize shareholder value - marketscreener.com
Profusa Inc Profusa Initiates Board-Led Process To Evaluate Strategic Alternatives And Maximize Shareholder Value - TradingView
Profusa starts deal review after Lumee Oxygen completes two EU audits - Stock Titan
Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value - marketscreener.com
[EFFECT] Profusa, Inc. SEC Filing - Stock Titan
EFFECT: Others - Moomoo
PFSA Technical Analysis | Trend, Signals & Chart Patterns | PROFUSA INC (NASDAQ:PFSA) - ChartMill
424B3: Prospectus - Moomoo
Profusa (PFSA) registers 179.3M resale shares, up to $100M ELOC funding - Stock Titan
Profusa (NASDAQ: PFSA) files S-1 for 179M-share resale and $100M equity line - Stock Titan
PFSA SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Why did PFSA stock surge 80% pre-market today? - MSN
Profusa amends debt agreement and receives Nasdaq deficiency notice By Investing.com - Investing.com Australia
Profusa Faces Nasdaq Listing Risk Amid Financing Amendments - TipRanks
Profusa amends debt agreement and receives Nasdaq deficiency notice - Investing.com
Profusa Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Profusa (NASDAQ: PFSA) revises convertible note as Nasdaq listing risk rises - Stock Titan
Profusa (PFSA) resale S-1 details 179M shares and $100M equity line - Stock Titan
Trending Stocks Today | Profusa Soars 26.07% Pre-Market - Moomoo
Profusa Announces PanOmics Assay Know-How Acquisition Agreement - TipRanks
Profusa to Acquire PanOmics Assay Know-How From Bio Insights for $30 Million in Preferred Stock - TradingView
Profusa (NASDAQ: PFSA) to acquire PanOmics assay assets in $30M stock deal - Stock Titan
Profusa, Inc. Issues $1.1 Million Senior Secured Convertible Promissory Note and Warrant to Ascent Partners Fund LLC - Minichart
Profusa Raises $1.0 Million From Ascent via Secured Convertible Note; Issues $0.50 Warrant, Adds Lock-Up - TradingView
Profusa (NASDAQ: PFSA) adds secured convertible note and 3.33M-share warrant - Stock Titan
PFSA Financials: Income Statement, Balance Sheet & Cash Flow | Profusa Inc - Stock Titan
Profusa (PFSA) Stock Dividend Growth (Underperforming) 2026-04-20Trending Buy Opportunities - Cổng thông tin điện tử tỉnh Lào Cai
What's going on with Profusa stock Tuesday? - MSN
Profusa’s Next-Generation Biosensor Technology: Real-Time Biochemistry Monitoring for Chronic Disease Management and Telemedicine Applications - Minichart
Profusa, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Profusa (NASDAQ: PFSA) outlines Lumee biosensor pipeline, funding and 1-for-75 reverse split - Stock Titan
Profusa, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Profusa Amends Financing and Pursues PanOmics Acquisition - TipRanks
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Profusa Inc Stock (PFSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):